Global Pharma under lens after US FDA flags contamination risk over EzriCare Artificial Tears

US regulator Food and Drug Administration warned consumers “not to purchase or use EzriCare Artificial Tears due to potential contamination.” Manufacturing plant Global Pharma Health Care Limited company is situated in Chennai, which has a contract of supplying through others to the US market.